Drug Profile
Niosomal plumbagin-betadex
Alternative Names: Beta-cyclodextrin-plumbagin; Niosomal plumbagin-beta-cyclodextrin; Plumbagin-beta-cyclodextrin complexLatest Information Update: 30 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Cardiotonics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 31 Aug 1999 New profile
- 31 Aug 1999 Preclinical development for Cancer in India (Unknown route)